Contraception
Volume 82, Issue 1 , Pages 113-118 , July 2010

Guidance on medical eligibility criteria for contraceptive use: identification of research gaps

  • Suzanne G. Folger

      Affiliations

    • Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Kathryn M. Curtis

      Affiliations

    • Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    • ,
  • Naomi K. Tepper

      Affiliations

    • Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    • ,
  • Mary E. Gaffield

      Affiliations

    • Department of Reproductive Health and Research, World Health Organization, Geneva 1211, Switzerland
    • ,
  • Polly A. Marchbanks

      Affiliations

    • Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA

Received 18 February 2010 ,Accepted 18 February 2010.

References 

  1. United States Medical Eligibility Criteria for Contraceptive Use . Adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use. 4th ed.. MMWR; 2010;
  2. World Health Organization . Medical Eligibility Criteria for Contraceptive Use. 4th ed.. Geneva: World Health Organization; 2009;
  3. Tepper NK, Paulen ME, Marchbanks PA, Curtis KM. Safety of contraceptive use among women with peripartum cardiomyopathy: a systematic review. Contraception. 2010;[in this issue]
  4. Zapata LB, Whiteman M, Tepper NK, Jamieson DJ, Marchbanks PA, Curtis KM. Intrauterine device use among women with uterine fibroids: a systematic review. Contraception. 2010;[in this issue]
  5. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527–530
  6. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235–241
  7. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303:242–249
  8. Catalano PM. Management of obesity in pregnancy. Obstet Gynecol. 2007;109:419–433
  9. Robinson HE, O'Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol. 2005;106:1357–1364
  10. Grimes DA, Shields WC. Family planning for obese women: challenges and opportunities. Contraception. 2005;72:1–4
  11. American College of Obstetricians and Gynecologists . Obesity in pregnancy. ACOG Committee Opinion No. 315. Obstet Gynecol. 2005;106:671–675
  12. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspec Sex Reprod Health. 2006;38:90–96
  13. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118:978–980
  14. Lidegaard O, Lokkegaard E, Svendson AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;b2890:339
  15. Martinez F, Avecilla A. Combined hormonal contraception and venous thromboembolism. Eur J Contracept Reprod Health Care. 2007;12:97–106
  16. Jick SS, Hagberg KW, Hernandez RK, Kaye JA. Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal thromboembolism. Contraception. 2010;81:16–21
  17. Heinemann LAJ, Dinger JC. Range of published estimates of venous thromboembolism incidence in young women. Contraception. 2007;75:328–336
  18. Nightingale AL, Lawrenson RA, Simpson EL, Williams TJ, MacRae KD, Farmer RDT. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracep Reprod Health Care. 2000;5:265–274
  19. Trussell J, Guthrie KA, Schwarz EB. Much ado about little: obesity, combined hormonal contraceptive use and venous thrombosis. Contraception. 2008;77:143–146
  20. Faculty of Family Planning and Reproductive Health Care Royal College of Obstetrics and Gynecology. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC) - 2009 edition. Available from: URL: http://www.fsrh.org/admin/uploads/UKMEC.html.
  21. Speerhas R. Drug metabolism in malnutrition and obesity: clinical concerns. Cleve Clin J Med. 1995;62:73–75
  22. Edelman AB, Carlson NE, Cherala G, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception. 2009;80:119–127
  23. Trussell J, Schwarz EB, Guthrie K. Obesity and oral contraceptive pill failure. Contraception. 2009;79:334–338
  24. Burkman RT, Fisher AC, Wan GJ, Barnowski CE, LaGuardia KD. Association between efficacy and body weight or body mass index for two low-dose oral contraceptives. Contraception. 2009;79:424–427
  25. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data. Fertil Steril. 2002;77:S13–S18
  26. Zhu BP, Rolfs RT, Nangle BE, Horan JM. Effect of the interval between pregnancies on perinatal outcomes. N Engl J Med. 1999;340:589–594
  27. Ip S, Chung M, Raman G, Trikalinos TA, Lau J. A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. Breastfeed Med. 2009;4(Suppl 1):S17–S30
  28. Kapp N, Curtis K, Nanda K. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception. 2010;[in this issue]
  29. Kapp N, Curtis K. Combined oral contraceptive use among breastfeeding women: a systematic review. Contraception. 2010;[in this issue]
  30. Truitt ST, Fraser AB, Grimes DA, Gallo MF, Schulz KF. Hormonal contraception during lactation. Systematic review of randomized controlled trials. Contraception. 2003;68:233–238
  31. Glion consultation on strengthening linkages between reproductive health and HIV/AIDS. http://whqlibdoc.who.int/hq/2006/WHO_HIV_2006.02_eng.pdf2006;
  32. Curtis KM, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS. 2009;23:S55–S67
  33. Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007;197:144–148

☆ The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the World Health Organization.

PII: S0010-7824(10)00059-4

doi: 10.1016/j.contraception.2010.02.015

Contraception
Volume 82, Issue 1 , Pages 113-118 , July 2010

Article Tools